| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |